Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rupert Vessey


  • Evp, Research & Early Dev. at Bristol Myers Squibb Co (BMY), 2020-05-05
  • Pres., Research And Early Dev. at Celgene Corp (CELG), 2019-11-22
  • Director at Bio-Techne Corp (TECH), 2019-10-28
  • Director at Juno Therapeutics Inc. (JUNO), 2017-04-19
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BMY $60.59 84,308 Officer 48,343 2020-03-02 Filing
CELG $120.15 778 Officer 0 2017-06-15 Filing
CELG $120.18 4,007 Officer 778 2017-06-15 Filing
CELG $124.42 4,000 Officer 778 2017-03-01 Filing
CELG $123.18 2,500 Officer 1,150 2016-11-22 Filing